Cyclin C Regulation of the Stress Response and Drug Sensitivity in Breast Cancer
Abstract
One mechanism by which malignancies are protected from cytotoxic agents is through aberrant activation of the stress response pathway. The yeast C-type cyclin (UME3) is a repressor of stress response genes. To relieve this repression, the UME3 protein (Ume3p) is rapidly destroyed when cells are exposed to several types of stress. To determine if this novel regulatory strategy is conserved, the human C-type cyclin (HcycC) levels were monitored in cell lines exposed to stress and apoptotic inducers. An epitope tagged derivative of HcycC (HcycC-HA) was constructed and stability integrated into the human breast cancer cell line MCF-7. Exponential cultures were subjected to either heat shock (42C) or exposed to tumor necrosis factor alpha (TNFalpha). In both studies, HcycC levels were reduced compared to untreated controls. In addition, HcycC was rapidly destroyed when ectopically expressed in yeast subjected to heat shock. These findings are consistent with a model that down regulation of HcycC is part of the normal cellular response to stress. Moreover, these findings suggest that the regulation of C-type cyclins is conserved from yeast to man.
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 01, 2000
- Accession Number
- ADA394778
Entities
People
- Randy Strich
Organizations
- Fox Chase Cancer Center